汉族、维吾尔族老年男性2型糖尿病合并骨质疏松患者25羟维生素D水平分析

doi:10.3969/j.issn.1000-8535.2018.04.005

广州医药 ›› 2018, Vol. 49 ›› Issue (4): 17-19.DOI: 10.3969/j.issn.1000-8535.2018.04.005

汉族、维吾尔族老年男性2型糖尿病合并骨质疏松患者25羟维生素D水平分析

周扬¹, 陈菲², 马锋³, 黄榕²

1 石河子大学医学院(石河子 832000);
2 新疆维吾尔自治区人民医院干部保健中心三病区 (乌鲁木齐 830001);
3 新疆医科大学 (乌鲁木齐 830054)

收稿日期:2018-02-07 出版日期:2018-07-20 发布日期:2021-11-29
通讯作者: 黄榕,E-mail:hr700612@163.com

Analysis of 25 hydroxy vitamin D level for elderly male patients with T2DM complicated with osteoporosis in Hans and Uyghurs

ZHOU Yang¹, CHEN Fei², MA Feng³, HUANG Rong²

1 The Medical College of Shihezi University, Xinjiang, Shihezi 832000, China;
2 The Third Department of Health Care, People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang, Urumqi 830001,China;
3 Xinjiang Medical University, Urumqi 830054, China

Received:2018-02-07 Online:2018-07-20 Published:2021-11-29

摘要/Abstract

摘要： 目的分析25羟维生素D[25(OH)D]在新疆汉族及维吾尔族老年男性2型糖尿病(T2DM)合并骨质疏松(OP)患者中的水平及与骨密度(BMD)的相关性。方法收集住院的汉族、维吾尔族老年男性T2DM患者281例,根据民族及骨密度值将其分为汉族非骨质疏松(NOP)组127人(A组)、汉族骨质疏松(OP)组21人(B组)、维族NOP组103人(C组)、维族OP组30人(D组),记录四组患者的25(OH)D水平并进行比较,分析25(OH)D与BMD的相关性。结果同一民族中,B组的25(OH)D低于A组(P<0.05),D组的25(OH)D低于C组(P<0.05); T2DM合并OP患者中,D组的25(OH)D低于B组(P<0.05); 相关性分析显示,25(OH)D与BMD呈正相关。结论维吾尔族老年男性T2DM合并OP患者较汉族患者的25(OH)D水平低,25(OH)D水平低的T2DM患者更易合并OP,25(OH)D检测有助于识别T2DM患者合并OP的风险。

关键词: 2型糖尿病, 骨质疏松, 25羟维生素D

Abstract: Objective To analysis the level of 25 hydroxy vitamin D[25(OH)D] in Xinjiang Han and Uyghur elderly male patients with T2DM and osteoporosis, and the correlation between 25(OH)D levels and bone mineral density(BMD). Methods We collected 281 cases of T2DM patients from Hans and Uyghurs, divided them into four groups according to the nationality and BMD: Han non-osteoporosis(NOP) group including 127 cases(group A), Han osteoporosis(OP) group 21 cases(group B), Uyghur NOP group 103 cases(group C), Uyghur OP group 30 cases(group D). Recorded and compared their 25(OH)D levels, and analyzed the correlation between 25(OH)D levels and BMD. Results In the same nationality,the level of 25(OH)D in group B were lower than those in group A(P<0.05), and group D were lower than those in group C(P<0.05); In T2DM patients combined with OP, the levels of 25(OH)D in group D were lower than those in group B(P<0.05); Correlation analysis showed that 25(OH)D was positively correlated with BMD. Conclusion The level of 25(OH)D in elderly male patients with T2DM combined with osteoporosis, those of Uyghurs are lower than those of Hans. T2DM patients with lower 25(OH)D level are more likely to combine OP. The 25(OH)D level test may help to identify the risk of combining OP in T2DM patients.

Key words: Type 2 diabetes mellitus, Osteoporosis, 25 hydroxy vitamin D

周扬, 陈菲, 马锋, 黄榕. 汉族、维吾尔族老年男性2型糖尿病合并骨质疏松患者25羟维生素D水平分析[J]. 广州医药, 2018, 49(4): 17-19.

ZHOU Yang, CHEN Fei, MA Feng, HUANG Rong. Analysis of 25 hydroxy vitamin D level for elderly male patients with T2DM complicated with osteoporosis in Hans and Uyghurs[J]. Guangzhou Medical Journal, 2018, 49(4): 17-19.

参考文献

[1] 田勇.2型糖尿病并发骨质疏松临床分析[J]. 当代医学,2014, 20(l):70-71.
[2] CHINESE DIABETES SOCIETY. Guidelines for prevention and treatment of type 2 diabetes in China (2013 Edition)[J]. Chin J Diabetes Mellitus, 2014, 6(7):447-498.
[3] WORLD HEALTH ORGANIZATION. Prevention and management of steoprorsis[J]. World Health Organ Tech Rep Ser, 2003(921):1-164.
[4] ANAFOROGLU I, NAR-DEMIRER A, BASCIL-TUTUNCU N, et al.Prevalence of osteoporosis and factors affecting bone mineral density among postmenopausal Turkish women with type 2 diabetes[J]. J Diabetes Complications, 2009, 23(1):12-17.
[5] JACKULIAK P, PAYER J. Osteoporosis, fractures, and diabetes[J]. Int J Endocrinol, 2014, 2014(3):820615.
[6] 裴育,巴建明.1型和2型糖尿病与骨质疏松症的关系[J]. 中华糖尿病杂志,2016,8(1):12-14.
[7] RATHMANN W, KOSTEV K.Fracture risk in patients with newly diagnosed type 2 diabetes; a retrospective database analysis in primary care[J]. J Diabetes Complications, 2015, 29(6): 766-770.
[8] 蒋娥,王自正,孟庆乐,等.老年男性2型糖尿病患者骨密度变化与血糖的相关性[J]. 中国骨质疏松杂志,2013,19(9):961-963.
[9] KANAZAWA L, YAMAGUCHI T, YAMAMOTO M. Relationship between treatments with insulin oral hypoglycemic agents versus the presence of vertebral fractures in type 2 diabetes mellitus[J]. J Bone and Miner Metab, 2010,28(12):554-560.
[10] 张丽丽,刘敏燕,成晓玲,等.维生素D与骨代谢生化标志物的相关性研究[J]. 标记免疫分析与临床, 2015,22(10):949-955.
[11] 邱明才,马中书.应该高度关注维生素D在人体中的广泛生物学作用[J]. 中华内分泌代谢杂志,2013,29(10):825-826.
[12] LIPS P, van SCHOOR N M. The effect of vitamin D on bone and osteoporosis[J]. Best Pract Res Clin Endocrinol Metab, 2011, 25(4): 585-591.
[13] RIZZOLI R, BOONEN S, BRANDI M L, et al. Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis(ESCEO)[J]. Curr Med Res Opin, 2013, 29(4): 1-9.
[14] 刘丹丹,常虹,谈敏,等.男性2型糖尿病患者25羟维生素D3及骨代谢指标的变化分析[J]. 安徽医药, 2015,19(2):288-291.

汉族、维吾尔族老年男性2型糖尿病合并骨质疏松患者25羟维生素D水平分析

Analysis of 25 hydroxy vitamin D level for elderly male patients with T2DM complicated with osteoporosis in Hans and Uyghurs

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 7

编辑推荐

Metrics

本文评价

[1]	麦高阳, 李鲁强. 绝经前后女性2型糖尿病患者C肽水平与代谢综合征的关系[J]. 广州医药, 2021, 52(6): 76-79.
[2]	骆超锋, 梁叠锋, 关国宏. 瑞格列奈联合胰岛素治疗2型糖尿病临床疗效及对患者血糖水平的影响[J]. 广州医药, 2021, 52(4): 65-67.
[3]	王曦龄, 李军, 李思源, 高群, 王双. 新疆绝经后女性2型糖尿病LRP5基因rs3736228、rs3781586位点的基因多态性及突变与糖、脂、骨代谢关系的研究[J]. 广州医药, 2021, 52(1): 6-11.
[4]	张浩航, 曾建红, 平丽, 李佩兰. 2型糖尿病男性患者血尿酸水平与骨质疏松及临床骨折的相关性研究[J]. 广州医药, 2020, 51(5): 46-49.
[5]	谭静. 基于互联网平台的健康管理模式对2型糖尿病患者血糖管理的效果[J]. 广州医药, 2020, 51(5): 111-114.
[6]	黄星, 欧锐金, 李国兴. 富血小板血浆联合强骨胶囊对大鼠骨质疏松性骨折骨愈合的影响[J]. 广州医药, 2020, 51(4): 1-4.
[7]	张燕华, 唐奇志, 陈聪, 刘剑文. 利拉鲁肽与二甲双胍对新诊断2型糖尿病患者骨代谢的影响[J]. 广州医药, 2018, 49(5): 48-51.